期刊文献+

右美托咪啶在脓毒症ARDS患者机械通气治疗中的应用 被引量:11

下载PDF
导出
摘要 目的观察右美托咪啶对脓毒症急性呼吸窘迫综合征(ARDS)机械通气患者的镇静、抗炎效应。方法将80例脓毒症ARDS机械通气患者随机分为观察组和对照组各40例,两组均使用芬太尼注射液行基础镇痛,分别使用右美托咪定及咪达唑仑镇静处理,镇静目标Ramsay分级Ⅲ~Ⅳ级;比较两组治疗72 h后呼吸抑制发生率、低血压、心动过缓及谵妄发生率、唤醒时间,比较入院前及治疗120 h后血清降钙素原(PCT)、乳酸(Lac)水平变化。结果治疗72 h后,观察组呼吸抑制、低血压、谵妄发生率均较对照组降低,停药后唤醒时间缩短,但心动过缓发生率较高,P均〈0.05;120 h后两组血清PCT、Lac均较治疗前下降,观察组较对照组更低(P均〈0.01)。结论脓毒症ARDS患者机械通气治疗中应用右美托咪啶,唤醒时间短,呼吸抑制、低血压、谵妄发生率低,并有良好的抗炎作用。
出处 《山东医药》 CAS 北大核心 2016年第2期58-59,共2页 Shandong Medical Journal
基金 广东省佛山市医学科技攻关项目(2014AB000622)
  • 相关文献

参考文献13

  • 1王常永,商敏,程林,周青山.右美托咪啶和咪达唑仑用于危重症患者镇静效应的比较[J].海南医学院学报,2011,17(5):695-697. 被引量:29
  • 2李锋,苏美仙.右美托咪啶在ICU患者中的临床应用进展[J].昆明医科大学学报,2012,33(S1):84-87. 被引量:3
  • 3Hsing CH, Lin CF, So E, et al. Alpha-2adrenoceptor agonist- dexmedetomidine protects septic acute kidney injury through in- creasing BMP-7 and inhibiting HDAC2 and HDAC5 [ J ]. Am J Physiol Renal Physiol, 2012,303 (10) : 1443-1453.
  • 4Shi QQ, Wang H, Fang H. Dose-response and mechanism of pro- tective functions of selective alpha-2 agonist dexmedetomidine on a- eute lung injury in rats[J]. Sandi Med J, 2012,3(4) :375-381.
  • 5Taniguchi T, Kidani Y, Kanakura H, et al. Effects of dexmcdeto- midine on mortality rate and inflammatory responses to endotoxin- induced shock n rates[J]. Crit Care Med, 2004,32(6) :1322- 1326.
  • 6Qiao H, Sanders RD, Ma D, et al. Sedation improves early out- come in severely septic sprague dawley rats[ J]. Crit Care, 2009, 13(4) :R136.
  • 7Venn RM, Bryant A, Hall GM, et al. Effects of dexmedetomidine- on adrenoeortical function, and the cardiovascular, endocrine andin- flammatory responses in post-operative patients needing sedationin he intensive care unit[ J]. Br J Anaesth, 2001,86 (5) :650-656.
  • 8Hausenloy DJ, Tsang A, Moeanu biN, et al. Ischemic precondi- tioning protects by activating prosurvival kinases at reperfusion [ J ]. Am J Physiol Heart Cire 15hysiol, 2005,288(2) :971-976.
  • 9Kocoglu H, Ozturk H, Ozturk H, et al. 'Effect of dexmcdetomidine on ischemia-reperffusion injury in rat kidney: A hstopathologic study[ J]. Renal Failure, 2009,31 ( 1 ) :70-74.
  • 10汤耀平,林丽玲,刘付宁,刘玲,曹铭辉.右美托咪定对舌癌患者围术期免疫功能的影响[J].岭南急诊医学杂志,2012,17(2):115-117. 被引量:2

二级参考文献65

  • 1王晓芝,吕长俊,高福全,李笑宏,颜卫峰,宁方玉.目标指导下治疗脓毒性休克的疗效观察[J].中国危重病急救医学,2006,18(11):661-664. 被引量:13
  • 2管向东,寇秋野.感染性休克血流动力学的监测指标[J].创伤外科杂志,2007,9(2):97-99. 被引量:28
  • 3Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference. Crit Care Med, 2003,31 : 1250-1256.
  • 4James JH, Luchette FA, Mccarter FD, et al. Lactate is an unreliable indicator of tissue hypoxia in injury or sepsis. Lancet, 1999,354: 505 -508.
  • 5Nguyen HB,Rivers EP, Knoblich BP, et al. Early lactate clearance is associated with improved outcome in severe sepsis and septic shock. Crit Care Med,2004,32:1637-1642.
  • 6Corley KT, Donaldson LL, Furr MO. Arterial lactate concentration, hospital survival, sepsis and SIRS in critically ill neonatal foals. Equine Vet J,2005,37:53-59.
  • 7Gnanasegaram D, Hugher N. Towards evidence based emergenay medicine:best BETs from the Manchester Royal Infirmary. Bet 1. Lactate clearance a better predictor of mortality than initial lactate level lactate clearance a better predictor of mortality than initial lactate level. Emerg Med J,2008,25:593-594.
  • 8Gando S, Nanzaki S, Sasaki S, et al. Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med, 1998,26:2005-:2009.
  • 9Voves C, Wuillemin WA, Zeerleder S. International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients. Blood Coagul Fibrin Olysis,2006,17:445-451.
  • 10Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med ,2001,344:699-709.

共引文献110

同被引文献129

引证文献11

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部